OXYCODONE/APAP is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct Rx. The primary component is Acetaminophen; Oxycodone Hydrochloride.
| Product ID | 61919-432_a7e8a9d1-15a3-7923-e053-2995a90ae440 |
| NDC | 61919-432 |
| Product Type | Human Prescription Drug |
| Proprietary Name | OXYCODONE/APAP |
| Generic Name | Oxycodone/apap |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-06-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202677 |
| Labeler Name | DIRECT RX |
| Substance Name | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE |
| Active Ingredient Strength | 325 mg/1; mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2016-06-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202677 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-15 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202677 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-06-15 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202677 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-15 |
| Inactivation Date | 2020-01-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 61919-432 | OXYCODONE/APAP | OXYCODONE/APAP |
| 61919-524 | OXYCODONE/APAP | OXYCODONE/APAP |
| 61919-835 | Oxycodone/APAP | Oxycodone/APAP |
| 72189-375 | Oxycodone/APAP | Oxycodone/APAP |
| 72189-397 | Percocet | Oxycodone/APAP |
| 72189-398 | Percocet | Oxycodone/APAP |